Global Blood Gas and Electrolyte Analyzers Market Outlook 2022

Blood gas and electrolyte analyzers are used to measure different parameters from whole blood samples, such as pH, blood gas (pCO2 and pO2), electrolytes, and metabolites. The pH value of blood and serum or plasma is an indicator of the balance between the blood, renal (kidney), and lung (respiratory) systems, while the pCO2 value of arterial blood is used to assess efficient elimination of carbon dioxide from the body, a by-product of metabolism; and the pO2 value of arterial blood is a measure of oxygen absorbance by the body in the lungs. Electrolytes and metabolites give further information about body metabolism.
Growth in number of patients being treated in ICUs, NICUs, and emergency departmen ts; rise in patients suffering from chronic diseases; technological advancement in blood gas & electrolyte analyzers, and increase in number of product approvals are the major factors that drive the market growth. However, complexity involved in the interpretation of blood analysis data act as a restraining factor for the market growth. Increase in investment by major medical diagnostics giants and improvement in the healthcare facilities in Asia-Pacific provide growth opportunities for the market.

The global Blood Gas and Electrolyte Analyzers market was valued at US$ 3061.8 million in 2020 and is expected to reach US$ 4019.5 million by the end of 2027, growing at a CAGR of 3.5% during 2021-2027.
This report focuses on Blood Gas and Electrolyte Analyzers volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Blood Gas and Electrolyte Analyzers market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Blood Gas and Electrolyte Analyzers Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
i-Stat (Abbott Laboratories)
GEM Premier (Instrumentation Laboratory)
ABL Flex (Radiometer)
Cobas (Roche Diagnostics)
RAPID Series (Siemens Healthineers)
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers (ASC)
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Abbott Laboratories
ERBA Mannheim
Instrumentation Laboratory Company
Medica Corporation
Nova
OPTI Medical Systems
Radiometer
Roche
Siemens